← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2021-04-13

Drug application

FDA Application #

ANDA213226

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

Manufacturer

Novadoz Pharmaceuticals LLC

First approval

2021-04-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown